Optimize Your Trial With Digital Cognitive Testing via ERT eCOA
ERT’s eCOA platform now offers scientifically validated computerized cognitive assessments, created by Cogstate and optimized to establish how a medication impacts cognitive function. This single solution helps you remove many of the complexities of completing cognitive assessments from your trial.
■ 33% reduction in start-up times
■ 66% reduction in test administration times
■ 98% reduction in administration, recording or scoring errors
■ 50% reduction in placebo response rate
Drive Efficiencies With A Single Comprehensive Solution
Completing cognitive assessments in clinical trials is no easy task. They’re extremely resource intensive, and can negatively impact patient compliance, study timelines, and even signal detection when measuring a drug’s efficacy.
Empowered by ERT and Cogstate’s combined single-device solution, you can drive new efficiencies in your trials, including:
- Single Learning Management System for study teams
- Single device and log-in for patients
- Assessments completed at clinic or virtually
- Automated, error-free assessment scoring
- Single point of contact for study support
Bring Unmatched Expertise to Your Trial
Deliver neurocognitive and technological expertise to your trial that will enable you to improve decision-making and streamline data collection.
Cogstate’s computerized cognitive assessments are valid, highly sensitive to drug affect, and accepted by regulators for inclusion criteria and safety and efficacy endpoints. They’re quick and easy for patients to use, no matter where they are in the world or what language they speak.
ERT’s eCOA solution is adaptable to both provisioned and BYOD approaches. In addition to collecting outcome assessments, ERT can provide scientific consulting, site training, statistical analysis, and regulatory support.
Our team of experts is always available to address any questions you may have about our eCOA solutions.
Submit your contact information and we’ll be in touch shortly.